These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23661597)

  • 21. Inhibitory effects of tricin derivative from Sasa albo-marginata on replication of human cytomegalovirus.
    Akuzawa K; Yamada R; Li Z; Li Y; Sadanari H; Matsubara K; Watanabe K; Koketsu M; Tuchida Y; Murayama T
    Antiviral Res; 2011 Sep; 91(3):296-303. PubMed ID: 21745500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus-seropositive kidney-transplant patients.
    Wéclawiak H; Kamar N; Mengelle C; Guitard J; Esposito L; Lavayssière L; Cointault O; Ribes D; Rostaing L
    J Med Virol; 2008 Jul; 80(7):1228-32. PubMed ID: 18461614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains.
    Ponroy N; Taveira A; Mueller NJ; Millard AL
    J Med Virol; 2015 Jan; 87(1):141-53. PubMed ID: 24976258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is human cytomegalovirus a target in cancer therapy?
    Johnsen JI; Baryawno N; Söderberg-Nauclér C
    Oncotarget; 2011 Dec; 2(12):1329-38. PubMed ID: 22246171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
    Kaptein SJ; Efferth T; Leis M; Rechter S; Auerochs S; Kalmer M; Bruggeman CA; Vink C; Stamminger T; Marschall M
    Antiviral Res; 2006 Feb; 69(2):60-9. PubMed ID: 16325931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel inhibitors of human CMV.
    Andrei G; De Clercq E; Snoeck R
    Curr Opin Investig Drugs; 2008 Feb; 9(2):132-45. PubMed ID: 18246516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship.
    Melnick M; Sedghizadeh PP; Allen CM; Jaskoll T
    Exp Mol Pathol; 2012 Feb; 92(1):118-25. PubMed ID: 22101257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus.
    Allice T; Busca A; Locatelli F; Falda M; Pittaluga F; Ghisetti V
    J Antimicrob Chemother; 2009 Mar; 63(3):600-8. PubMed ID: 19147520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human cytomegalovirus induces upregulation of arginase II: possible implications for vasculopathies.
    Yaiw KC; Mohammad AA; Taher C; Wilhelmi V; Davoudi B; Strååt K; Assinger A; Ovchinnikova O; Shlyakhto E; Rahbar A; Koutonguk O; Religa P; Butler L; Khan Z; Streblow D; Pernow J; Söderberg-Nauclér C
    Basic Res Cardiol; 2014 Mar; 109(2):401. PubMed ID: 24442486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human cytomegalovirus DNA replication: antiviral targets and drugs.
    Mercorelli B; Sinigalia E; Loregian A; Palù G
    Rev Med Virol; 2008; 18(3):177-210. PubMed ID: 18027349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics.
    Baumgarten P; Michaelis M; Rothweiler F; Starzetz T; Rabenau HF; Berger A; Jennewein L; Braczynski AK; Franz K; Seifert V; Steinbach JP; Allwinn R; Mittelbronn M; Cinatl J
    Neuro Oncol; 2014 Nov; 16(11):1469-77. PubMed ID: 25155358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct infection of colony forming unit-megakaryocyte by human cytomegalovirus contributes the pathogenesis of idiopathic thrombocytopenic purpura.
    Xiao Y; Lin W; Liu Q; Jin R; Fei H
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):555-7. PubMed ID: 17219966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection of human cytomegalovirus in cultured human gingival tissue.
    Hai R; Chu A; Li H; Umamoto S; Rider P; Liu F
    Virol J; 2006 Oct; 3():84. PubMed ID: 17022821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir.
    Mattes FM; Hainsworth EG; Hassan-Walker AF; Burroughs AK; Sweny P; Griffiths PD; Emery VC
    J Infect Dis; 2005 Jan; 191(1):89-92. PubMed ID: 15593008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response.
    Baldanti F; Lilleri D; Campanini G; Comolli G; Ridolfo AL; Rusconi S; Gerna G
    J Antimicrob Chemother; 2004 Mar; 53(3):536-9. PubMed ID: 14739146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment.
    Massari S; Mercorelli B; Sancineto L; Sabatini S; Cecchetti V; Gribaudo G; Palù G; Pannecouque C; Loregian A; Tabarrini O
    ChemMedChem; 2013 Aug; 8(8):1403-14. PubMed ID: 23757191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD133 suppresses neuroblastoma cell differentiation via signal pathway modification.
    Takenobu H; Shimozato O; Nakamura T; Ochiai H; Yamaguchi Y; Ohira M; Nakagawara A; Kamijo T
    Oncogene; 2011 Jan; 30(1):97-105. PubMed ID: 20818439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigational Antiviral Therapy Models for the Prevention and Treatment of Congenital Cytomegalovirus Infection during Pregnancy.
    Hamilton ST; Marschall M; Rawlinson WD
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human cytomegalovirus: challenges, opportunities and new drug development.
    Field AK
    Antivir Chem Chemother; 1999 Sep; 10(5):219-32. PubMed ID: 10574177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.